Orion Capital Management’s CVS Health CVS Stock Holding History

Orion Capital Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,000	Closed	-$69K	–	556
2025 Q2	$69K	Hold	1,000	–	–	0.03%	212
2025 Q1	$67.8K	Sell	1,000 -200	-17%	-$12K	0.03%	214
2024 Q4	$53.9K	Buy	+1,200	New	+$67.3K	0.02%	230
2024 Q3	–	Sell	-1,200	Closed	-$70.9K	–	214
2024 Q2	$70.9K	Sell	1,200 -2,400	-67%	-$150K	0.04%	186
2024 Q1	$287K	Sell	3,600 -1,874	-34%	-$143K	0.15%	94
2023 Q4	$432K	Sell	5,474 -740	-12%	-$52.7K	0.25%	70
2023 Q3	$434K	Sell	6,214 -1,639	-21%	-$116K	0.28%	70
2023 Q2	$543K	Hold	7,853	–	–	0.36%	60
2023 Q1	$584K	Hold	7,853	–	–	0.39%	52
2022 Q4	$732K	Buy	7,853 +240	+3%	+$23.2K	0.54%	47
2022 Q3	$726K	Hold	7,613	–	–	0.58%	41
2022 Q2	$705K	Buy	7,613 +500	+7%	+$48.8K	0.55%	41
2022 Q1	$720K	Hold	7,113	–	–	0.43%	50
2021 Q4	$734K	Hold	7,113	–	–	0.42%	55
2021 Q3	$604K	Hold	7,113	–	–	0.37%	60
2021 Q2	$594K	Hold	7,113	–	–	0.37%	59
2021 Q1	$535K	Hold	7,113	–	–	0.37%	59
2020 Q4	$486K	Buy	+7,113	New	+$463K	0.36%	59

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Orion Capital Management's CVS Position: Q3 2025 in Review

Orion Capital Management sold out of CVS Health (CVS) in Q3 2025, closing a stake of 1,000 shares — an estimated $69K sold.

Orion Capital Management first reported a position in CVS in Q4 2020 and held it in 18 quarters. The position peaked at $734K in Q4 2021. 1,834 funds tracked by Wall St. Rank hold CVS as of Q3 2025.

Orion Capital Management reported no remaining CVS Health position as of Q3 2025 after selling out during the quarter.
Orion Capital Management sold 1,000 CVS Health shares in Q3 2025, an estimated $69K.
Orion Capital Management first reported a position in CVS Health in Q4 2020 and held it in 18 quarters.
Orion Capital Management's CVS Health position peaked at $734K in Q4 2021.
1,834 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.

Based on Orion Capital Management's 13F filing for Q3 2025, filed 31 Oct 2025.